Danuta O.
- Country
- Poland
- Department
- NA
Research Overview
- Phase 3b, Randomized, Open‑Label, Active‑Controlled Trial Comparing Guselkumab Versus Risankizumab for Efficacy and Safety in Moderately to Severely Active Crohn’s Disease
- Phase 2a Randomized, Double‑Blind, Placebo‑Controlled Study of Subcutaneous MK‑8690 in Adults with Moderately to Severely Active Ulcerative Colitis
- Phase 3 Randomized Double‑Blind Study Evaluating Efficacy and Safety of JNJ‑78934804 Combination Therapy versus Guselkumab in Moderately to Severely Active Crohn’s Disease
Data & Insights
Has run more than one trial at 346 of 551 partner sites.
Specializations
Inflammatory Bowel Disease Expertise
The investigator specializes in treating Crohn's disease, with particular focus on both moderate to severe cases and fistulizing perianal manifestations. Their research encompasses innovative therapeutic approaches for managing complex presentations of this condition.
- Moderate to Severe Crohn's Disease Management
- Perianal Fistula Treatment
- Novel Therapeutic Applications
The investigator's work extends to evaluating new treatment modalities and combination therapies for optimal disease control.
Ulcerative Colitis Research
Their expertise encompasses the treatment of ulcerative colitis, focusing on both conventional and innovative therapeutic approaches. The investigator has extensive experience in managing varying degrees of disease severity, from mild to severe cases.
- Moderate to Severe UC Treatment
- Combination Therapy Approaches
- Clinical Response Assessment
Their research includes evaluation of both established treatments and emerging therapeutic options for UC management.
Hepatology Focus
The investigator's research extends to liver cirrhosis and its complications, with particular attention to fluid retention management and cardiovascular aspects of liver disease.
- Cirrhosis Management
- Fluid Balance Control
- Cardiovascular Complications
Their work includes investigating novel therapeutic combinations for improved patient outcomes in advanced liver disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.